StockData
GRI Bio, Inc. logo

GRI Bio, Inc. (GRI) KPIs and segments

GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.35−0.05 (-3.54%)

Close on Nov 17, 2026Market cap $2.95MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive GRI Bio's business

Coming soon

This tab will track the numbers specific to GRI Bio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?